|
|
|

|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
In the September 2011 issue of the British Journal of Psychiatry,
Priscilla K. Coleman, of Bowling Green State University in Ohio,
published an influential statistical analysis of the existing research
on the question of abortion and mental health (reported to be the
“largest quantitative estimate of mental health risks associated with
abortion available in the world literature”; see my Sept. 14 Zenit
article ). Her study concludes that women who have induced abortions
because of unwanted pregnancies suffer an incredible 81% increased risk
of mental health problems across a variety of categories.
|
|
Read more...
|
|
01/03/2012
|
|
by Willam E. May, Ph.D., Senior Research Fellow
|
|
Background and Introduction
In September 2010 Culture-of-Life.org posted on this website my article,
“Clarification of GIFT and IUI: Assisting or Substituting the Conjugal
Act?” Dr. José Florez had kindly corrected me for an article in Zenit in
which I confused GIFT or Gamete Intrafallopian Tube Transfer with IUI
or Homologous Intrauterine Insemination. He informed me that GIFT is
seldom used today in the U.S. because IUI is simpler and apparently more
effective.
Procedure
I will first describe GIFT/IUI, identify the moral issue, summarize
arguments given until 2011 pro and con the moral rightness of these
procedures, summarize a somewhat new argument in opposition to them
advanced in 2011 by Helen Watt, briefly reflect on the way “the language
of the body” relates to their morality, and offer a Conclusion.
|
|
Read more...
|
|
12/06/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
Translating Theory Into Treatments More Difficult Than Expected
WASHINGTON, D.C., NOV. 30, 2011 (Zenit.org).- Here is a question on
bioethics asked by a ZENIT reader and answered by the fellows of the
Culture of Life Foundation.
Q: Now that Geron has discontinued
its embryonic stem cell research, while at the same time adult stem
cell experiments have had a number of successful trials, what does this
mean for the stem cell debate? - FJF, Australia.
E. Christian Brugger replies:
Two
weeks ago a bombshell exploded on the field of human embryonic stem
cell (hESC) medicine. The undisputed leader in clinical research on
hESCs, Geron Corporation, announced that it was immediately ending its
clinical trials using hESCs and pulling out of the embryonic stem cell
business altogether to focus on cancer research.
|
|
Read more...
|
|
12/01/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
DENVER, Colorado, OCT. 10, 2011 (Zenit.org ).- The journal Nature
announced last Wednesday that scientists had for the first time
successfully derived "patient specific" stem cells from a cloned human
embryo. The last time such a claim was made was by the now discredited
Korean researcher Hwang Woo Suk, who alleged in a 2005 paper in the
journal Science that his team had procured stem cells from cloned human
embryos. Subsequent investigations found that Hwang had fabricated the
data.
|
|
Read more...
|
|
10/12/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
WASHINGTON, D.C., OCT. 5, 2011 (Zenit.org ).- Most are familiar with
the infamous "Tuskegee Syphilis Experiment" carried out on black
sharecroppers in Alabama between 1932-1972. U.S. government health
officials withheld effective treatment (penicillin after 1947) for
syphilis from 400 infected men for nearly 30 years in order to observe
the disease's progression.
Fewer know about the even darker Guatemala Affair. This should change
now that Obama's bioethical advisory commission published its recent
study, Ethically Impossible: STD Research in Guatemala from 1946 to
1948 . You might recall that shortly after taking office, the president
sent a letter to the members of his predecessor's bioethics advisory
council informing them that their appointments were being prematurely
terminated. That council, fairly balanced between defenders of
traditional values and social progressives, was not progressive enough
for the new president. He appointed his own slate, which, of course, he
is entitled to do since advisory councils serve at the pleasure of the
sitting president.
|
|
Read more...
|
|
10/11/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
WASHINGTON, D.C., SEPT. 14, 2011 (Zenit.org ).- Does induced abortion
increase a woman's risk of mental health problems? The question has been
asked continually over the past several decades with dozens of studies
indicating a positive correlation [1], but a few well-publicized studies
are arriving at the opposite conclusion.
An example of the latter is a widely quoted report in 2008 by the
American Psychological Association Task Force on Mental Health and
Abortion. The report confidently concludes that there is "no evidence
sufficient to support the claim" of a positive link between a woman's
abortion and increased mental distress. Abortion advocacy groups eagerly
jumped on the report to announce that abortion posed no threat at all
to a woman's mental health.
|
|
Read more...
|
|
09/15/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
DENVER, Colorado, AUG. 24, 2011 (Zenit.org ).- A problematic new
end-of-life medical form is rapidly gaining ascendency in U.S.
healthcare. It is called the "POLST" document. (In my own state of
Colorado, it's called a MOST document.) The acronym stands for Physician
Orders for Life-Sustaining Treatment. (MOST = "Medical Orders for Scope
of Treatment;" its provisions are almost identical across states.)
Click here to see an example of a standard POLST document.
The document consolidates on a single form provisions formerly dispersed
over several documents: it acts as a living will specifying the scope
of medical interventions a patient wishes in case of incapacitation; it
makes specific provision for a do-not-resuscitate order (DNR); it has a
box to check in the event a patient wishes to refuse treatment with
antibiotics; and it allows a patient to designate a proxy decision
maker.
|
|
Read more...
|
|
08/25/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
Most philosophical arguments against the personhood of embryos, fetuses
or comatose patients focus on consciousness as the capacity that
corresponds to the possession of moral value. Conscious human beings,
even minimally conscious, are obviously ‘one of us’ — have interests,
feel pain, perceive objects, and can offer at least rudimentary gestures
of self-report. Since they are “persons” they should not be subjected
to purely instrumental treatment such as lethal experimentation or
deadly dosages of drugs. Those who cannot exercise consciousness are
either not yet persons (e.g., embryos) or no longer persons (e.g.,
irreversibly comatose patients).
|
|
Read more...
|
|
08/09/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director, Fellows Program
|
|
WASHINGTON, D.C., JULY 6, 2011 (Zenit.org).- Political advocacy for
assisted suicide in the United States dates back to the eugenics
movement of the early 20th century and the failed Ohio euthanasia bill
of 1906.
Activists organized themselves in the 1930s around the former
Protestant minister Charles Potter (who first abandoned the Baptist and
then the Unitarian church because both were too conservative), and
formed the Euthanasia Society of America. The movement remained on the
social fringe until the 1970s, when the case of Karen Ann Quinlan
mobilized its energies.
|
|
Read more...
|
|
07/07/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director of the Fellows Program
|
|
WASHINGTON, D.C., JUNE 29, 2011 (Zenit.org ).- It's nice to know that the trusted aspirin maker, Bayer, is watching out for our daughters. The oral contraceptive producer of YAZ, Beyaz and Yasmin has been cited since 2008 by the FDA for failing to adequately address certain risks of its pills' active hormone drospirenone, a so-called "fourth generation" contraceptive drug.
|
|
Read more...
|
|
06/30/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
Introduction
Today legislation
requires patients to provide doctors, clinics, hospitals etc. with “advance
directives.” An advance directive is a document by which a person makes
provision for health care decisions in the event that, in the future, he or she
is no longer competent to make such decisions for himself or herself.
Advance directives are of two main types: (1) the “living
will” and (2) the “durable power of attorney for health care.” There is a third
type called a MOST form (medical order for scope of treatment), which is fast
becoming the form of choice in the US.
It combines into one form living will provisions, DNR orders, designate
of proxy care giver and has a doctor's signature making it a MEDICAL ORDER,
hence the name.
|
|
Read more...
|
|
06/01/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow and Director of the Fellows Program
|
WASHINGTON, D.C., MAY 25, 2011 (Zenit.org).- You might recall that last
summer a federal judge put a temporary hold on all government funding
for human embryonic stem cell research (hESC) in the United States.
In August 2010, Judge Royce Lamberth of the U.S. District Court for the
District of Columbia made headlines for halting the research on the
grounds that President Barack Obama's March 2009 executive order
revoking the President George Bush restrictions on hESC research was
illegal. The president's order, put into policy by the NIH, freed up
money for research upon stem cells derived from spare IVF embryos; but
the policy required that the actual destruction of the embryos be funded
privately.
The judge said the Obama policy violated the Dickey-Wicker Amendment ,
which prohibits federal money for research in which human embryos are
created or destroyed.
|
|
Read more...
|
|
05/26/2011
|
|
by E. Christian Brugger, D.Phil, Senior Fellow and Director of the Fellows Program
|
|
WASHINGTON, D.C., APRIL 6, 2011 (Zenit.org ).- Here is a question on
bioethics asked by a ZENIT reader and answered by the fellows of
the Culture of Life Foundation.
Q: The Catholic Church teaches that in vitro fertilization (IVF) is
always wrong. I understand this to be the case when embryos are made and
destroyed. But my doctor said that IVF could be used in a way that
wouldn't create and destroy "extra" embryos, even though it would lower
our chances for a successful pregnancy. If this is true, why is IVF
wrong when used by husbands and wives? K.M. -- Denver, Colorado
E. Christian Brugger offers the following response:
A: The question rightly identifies the wrongness of creating and
destroying (and we should add freezing) human embryos in and through the
process of IVF. But even if IVF was chosen only by married couples, and
those couples intended to create only as many embryos as they implant,
and they rejected the eugenic screening and destruction of disabled
embryos, IVF still would be gravely wrong.
|
|
Read more...
|
|
04/07/2011
|
|
by E. Christian Brugger, D. Phil, Senior Fellow and Fellows Director
|
|
WASHINGTON, D.C., MARCH 23, 2011 (Zenit.org ).- Here is a question on
bioethics asked by a ZENIT reader and answered by the fellows of the
Culture of Life Foundation.
Q: Could you please clarify the concept of a "savior sibling"? Some
argue that a child conceived to save his older brother or sister is
"conceived to be used." But the child per se is not used at all, only
the child's umbilical cord. Please clarify. Sincerely, D.V.M --
Bellflower, California
E. Christian Brugger offers the following response:
A: Lisa Nash, mother of the world's first "savior sibling," said she
would do "anything" to save her daughter's life.[1] Her daughter Molly
was diagnosed at birth (in 1994) with Fanconi Anemia, a serious genetic
disorder in which patients can suffer bone marrow failure, birth
defects, developmental abnormalities, a heightened risk of leukemia and
premature death. Lisa and her husband Jack were told that the best way
to help Molly was to give her a blood and marrow transplant from a
genetically matched sibling. But Molly was an only child. Her parents
had been considering conceiving again, but decided against it because of
the high probability -- about 25% -- that the child would suffer the
same illness.
|
|
Read more...
|
|
03/24/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
Surgery of this kind in the 1980’s
Spina bifida is a developmental congenital disorder caused by the
incomplete closing of the embryo’s neural tube. Some verterbrae
overlying the spinal cord are not fully formed and remain unfused and
open. This can cause long term mental and physical crippling to the
child and at times death in the womb due to the build up of fluid and
swelling in the brain.
In the 1980s it was possible, using prenatal screening, to detect
neural tube anomalies such as spina bifida and then to perform a
therapeutic action on the developing unborn child in the womb. The most
common procedure to treat this anomaly was to insert a shunt into the
child’s brain to drain the fluid thus releasing the pressure and
providing great benefit to the child’s neurological and physical
development. In fact, at a hearing at the US Senate sometime in the mid
1980’s, sponsored by then pro-life Senator Gordon Humphrey a couple and
their physician, with the child—at the time a born baby girl resting on
her mother’s lap—gave testimony in which they described the wonderful
surgery that had been done on the child while still in the womb after a
prenatal diagnosis had shown that she had suffered from a neural tube
defect and that fluids were building up in her cranium, exerting
pressure on her brain. This timely intervention was successful in
minimizing the harm this girl suffered after birth, and the surgical
intervention posed no serious risks either to the child or her mother.
The child still needed to have a shunt to remove fluids from her brain
after birth, but she did not suffer debilitating mental deficiencies and
other symptoms associated with spina bifida.
|
|
Read more...
|
|
03/23/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow
|
|
WASHINGTON, D.C., MARCH. 2, 2011 (Zenit.org ).- Here is a questions on bioethics asked by a ZENIT reader and answered by the fellows of the Culture of Life Foundation.
Q: What is the Catholic perspective on the ethics of parthenogenesis to produce stem cells from an ovum without fertilization by sperm? Thank you for your insights. Sincerely, R.P. Panama City Beach, Florida, USA
E. Christian Brugger offers the following response:
The term "parthenogenesis" (from the Greek words parthenos, "virgin" + genesis, "birth") refers to a form of asexual reproduction, naturally occurring among some insects, birds and lizards, in which an unfertilized egg develops without being fertilized by a male gamete.
|
|
Read more...
|
|
03/03/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
Is It Moral to Sell Contraceptives, Abortifacients?
WASHINGTON, D.C., FEB. 16, 2011 (Zenit.org).- Here is a question on
bioethics asked by a ZENIT reader and answered by the fellows of
the Culture of Life Foundation.
Q: Is it morally permissible to sell
something immoral to some one else, for instance, working at a pharmacy
and selling Plan B pills and contraceptives? -- D.K., Oxford, Michigan,
U.S.A.
William E. May offers the following response:
The question posed is broad. This answer will be limited to the
moral obligations of pharmacists to sell contraceptive and abortifacient
materials to their customers. We begin with a brief overview of
Catholic and pro-life principles on the issue.
|
|
Read more...
|
|
02/17/2011
|
|
by E. Christian Brugger, D.Phil., Senior Fellow
|
|
WASHINGTON, D.C., FEB. 2, 2011 (Zenit.org).- Here are two questions on
bioethics asked by ZENIT readers and answered by the fellows of the
Culture of Life Foundation.
Q: Can the adult stem cells or eyes or other organs of a murder victim
be used for the benefit of others, if the person was not murdered for
the purpose of harvesting his or her organs? -- Sister C., Lincoln,
Nebraska
E. Christian Brugger offers the following response:
A: Persons who wish to donate their organs when they die may formally
designate themselves as organ donors. This intention is often indicated
on some document such as a driver's license. The intention is not only
legitimate but can be praiseworthy (as John Paul II suggests in
"Evangelium Vitae," No. 86).
If persons have designated themselves as organ donors, then executing
their wishes after they die, even if they have been murdered, is
perfectly legitimate.
***
|
|
Read more...
|
|
02/03/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
Introduction
It is useful to begin by citing the teaching found in the 1987 document
issued by the Vatican’s Congregation for the Doctrine of the Faith,
Donum Vitae (Instruction on the Respect Due to Human Life in Its Origin
and on the Dignity of Procreation). This document addressed the morality
of both pre-natal screening and the use of therapeutic procedures on
human embryos. Regarding pre-natal diagnosis it affirmed: “pre-natal
diagnosis makes it possible to know the condition of the embryo and of
the fetus when still in the mother's womb. It…makes it possible to
anticipate earlier and more effectively certain therapeutic, medical or
surgical procedures. Such diagnosis is permissible, with the consent of
the parents after they have been adequately informed, if the methods
employed safeguard the life and integrity of the embryo and the mother,
without subjecting them to disproportionate risks. But this diagnosis is
gravely opposed to the moral law when it is done with the thought of
possibly inducing an abortion depending upon the results: a diagnosis
which shows the existence of a malformation or a hereditary illness must
not be the equivalent of a death-sentence.” Concerning therapeutic
measures applied to the human embryo it taught: “[O]ne must uphold as
licit procedures carried out on the human embryo which respect the life
and integrity of the embryo and do not involve disproportionate risks
for it but are directed towards its healing, the improvement of its
condition of health, or its individual survival. Whatever the type of
medical, surgical or other therapy, the free and informed consent of the
parents is required…The application of this moral principle may call
for delicate and particular precautions in the case of embryonic or
fetal life.”
|
|
Read more...
|
|
02/01/2011
|
|
by colfi_admin
|
|
Introduction
It is
useful to begin by citing the teaching found in the 1987 document issued by the
Vatican’s Congregation for the Doctrine of the Faith, Donum Vitae (Instruction on the Respect Due to Human Life in Its
Origin and on the Dignity of Procreation). This document addressed the morality
of both pre-natal screening and the use of therapeutic procedures on human
embryos. Regarding pre-natal diagnosis it affirmed: “pre-natal
diagnosis makes it possible to know the condition of the embryo and of the
fetus when still in the mother's womb. It…makes it possible to anticipate
earlier and more effectively certain therapeutic, medical or surgical
procedures. Such diagnosis is permissible, with the consent of the parents
after they have been adequately informed, if the methods employed safeguard the
life and integrity of the embryo and the mother, without subjecting them to
disproportionate risks. But this diagnosis is gravely opposed to the moral law
when it is done with the thought of possibly inducing an abortion depending
upon the results: a diagnosis which shows the existence of a malformation or a
hereditary illness must not be the equivalent of a death-sentence.” Concerning therapeutic
measures applied to the human embryo it taught: “[O]ne must uphold as licit procedures carried out on the human embryo
which respect the life and integrity of the embryo and do not involve
disproportionate risks for it but are directed towards its healing, the
improvement of its condition of health, or its individual survival.
Whatever the type of medical, surgical or other therapy, the free and informed
consent of the parents is required…The application of this moral principle may
call for delicate and particular precautions in the case of embryonic or fetal
life.”
|
|
Read more...
|
|
02/01/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
Introduction
It is
useful to begin by citing the teaching found in the 1987 document issued by the
Vatican’s Congregation for the Doctrine of the Faith, Donum Vitae (Instruction on the Respect Due to Human Life in Its
Origin and on the Dignity of Procreation). This document addressed the morality
of both pre-natal screening and the use of therapeutic procedures on human
embryos. Regarding pre-natal diagnosis it affirmed: “pre-natal
diagnosis makes it possible to know the condition of the embryo and of the
fetus when still in the mother's womb. It…makes it possible to anticipate
earlier and more effectively certain therapeutic, medical or surgical
procedures. Such diagnosis is permissible, with the consent of the parents
after they have been adequately informed, if the methods employed safeguard the
life and integrity of the embryo and the mother, without subjecting them to
disproportionate risks. But this diagnosis is gravely opposed to the moral law
when it is done with the thought of possibly inducing an abortion depending
upon the results: a diagnosis which shows the existence of a malformation or a
hereditary illness must not be the equivalent of a death-sentence.” Concerning
therapeutic measures applied to the human embryo it taught: “[O]ne must uphold as licit procedures carried
out on the human embryo which respect the life and integrity of the embryo and
do not involve disproportionate risks for it but are directed towards its
healing, the improvement of its condition of health, or its individual
survival. Whatever the type of medical, surgical or other therapy, the
free and informed consent of the parents is required…The application of this
moral principle may call for delicate and particular precautions in the case of
embryonic or fetal life.
|
|
Read more...
|
|
02/01/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
WASHINGTON, D.C., JAN. 12, 2011 (Zenit.org ).- Here is a question on bioethics asked by a ZENIT reader and answered by the fellows of the Culture of Life Foundation.
Q: I would love to see some more discussion or advice on the use of vaccines. [...] If my memory served me correctly, in the United States, all of the vaccines for Chicken Pox and the standard MMR [measles, mumps, rubella] protocols are developed from aborted children. Considering the ubiquity of these particular vaccines, I believe it is an issue that needs further exploration, discussion, and guidance from the Church and her thinkers. -- C.G., Charleston, South Carolina, USA
William E. May offers the following response:
|
|
Read more...
|
|
01/13/2011
|
|
by William E. May, Ph.D., Senior Fellow
|
|
The Reuters News
Agency reported on January 3 that the Federal Drug Administration had granted
the Advanced Cell Technology (ACT) firm the right to try out using embryonic
stem cells for treating macular degeneration, a common cause of blindness.
ACT’s chief scientific officer, Dr. Robert Lanza, said that ACT would
immediately recruit patients with age related macular degeneration and would
use stem cells procured by destroying embryonic human beings in an effort to
help these patients retain or recover their vision.
This essay will
first explain what macular degeneration is and note its different forms. It
will then focus on the morality of using human embryonic stem cells in efforts
to cure persons suffering from maladies, and then report and reflect on
relevant scientific evaluations of the therapeutic value efficacy of embryonic
stem cell research.
|
|
Read more...
|
|
01/11/2011
|
|
by Jennifer I. Kimball, Be.L., Director
|
|
Classical and theological discourse has always
held a unique and deeply significant respect for the womb. Indeed, the
womb is the place where the human person first experiences communion with
another, where it is nourished and grows under the care of maternal union,
where the developing person is most vulnerable and depends upon another in all
things.
|
|
Read more...
|
|
12/28/2010
|
|
by Administrator
|
|
Saving a Life, or Saving Money
December 15, 2020 Atlanta Journal Constitution
Meningococcal meningitis and meningococcal septicemia are the leading cause of death by infectious disease in early childhood. Even with early detection, the disease can kill in as little as four hours. Tragically, the rate of infection from these killers is three to seven times higher in infants than any other age group.
For years, a commitment by policymakers to eliminate the disease in the U.S. has yielded steady gains. But, under the Obama administration, there are concerning signs of a shift from saving lives to saving money. Now, some in the ethics community are questioning whether federal officials will fulfill their pledge to rid us of this disease and protect kids.
Read entire article in the Atlanta Journal Constitution...
|
|
12/16/2010
|
|
by William E. May, Ph.D. Senior Fellow
|
|
If an unborn baby in the fetal or embryonic stage of life dies as a result of a miscarriage it would not be immoral to do worthwhile scientific research using tissues
taken from it. But, as Germain Grisez noted in his massive book on
Difficult Moral Questions, a serious problem of conscience can
frequently face pro-life scientists and researchers regarding use of
tissues taken from embryonic or fetal human persons who were
intentionally aborted. The quandary is the following: Suppose that it is
not possible to do the research proposed by using spontaneously aborted
unborn babies who miscarry. For example, certain research may require using
embryonic/fetal tissue that must be fresh and not frozen or in any way
not normal and tissues from miscarried embryos/fetuses do not meet these
criteria. What should a conscientious pro-life person do if his
research center agreed to use biological material obtained as a result of the
intentional abortion of babies in their embryonic or fetal stages of
life? Grisez concluded that the scientist ought not participate in the
research nor cooperate with it in any way, even by advising a colleague
who would take his place but who is not as knowledgeable about the science involved as he is.
Grisez, however, thinks that if certain conditions are fulfilled, he
could offer this colleague some advice if it justified tolerating bad
side effects that would accompany the discovery of a procedure that
would also greatly benefit unborn babies (pp. 385-388).
|
|
Read more...
|
|
12/09/2010
|
|
by E. Christian Brugger, D. Phil, Senior Fellow in Ethics
|
|
WASHINGTON, D.C., NOV. 17, 2010 (Zenit.org).- Here is a question on
bioethics asked by a ZENIT reader and answered by the fellows of the
Culture of Life Foundation.
Q: Is it ever legitimate to remove or withhold life-sustaining
procedures from a patient in order to save excessive expenses to persons
other than that patient (e.g., the patient's family, the community)? --
W.G., Denver, USA
E. Christian Brugger offers the following response:
|
|
Read more...
|
|
11/18/2010
|
|
by William E. May, Ph.D., Senior Fellow
|
|
WASHINGTON, D.C., OCT. 6, 2010 (Zenit.org).- After my article on
Homologous Intrauterine Insemination appeared in ZENIT, José C. Florez,
M.D., Ph.D kindly corrected me for a misunderstanding of what Homologous
Intrauterine Insemination, or what he refers to as IUI (Intrauterine
Insemination), entails.
|
|
Read more...
|
|
10/07/2010
|
|
by E. Christian Brugger, D.Phil, Senior Fellow in Ethics
|
|
In May the Vatican announced that it was beginning a cooperative venture
in adult stem cell (ASC) research with the international biotech firm
NeoStem. Although the Catholic Church has patronized the sciences for
centuries, this is the first contractual foray into stem cell research
with a for-profit secular corporation. NeoStem (listed on the Amex) has
pharmaceutical operations in the US and China. The company is
launching a development program in adult stem cell therapies in addition
to building adult stem cell collection banks in the U.S. and China to
allow people to harvest and store their own stem cells as a type of
clinical insurance toward future medical need. Its Chinese division,
its website says, was established in order “to leverage the country’s
progressive stem cell environment” (www.neostem.com). NeoStem’s
operations with the Vatican—specifically with the Pontifical Council for
Culture (PCC)—will run through the corporation’s non-profit foundation
“Stem for Life.” The firm will bring to the relationship its
considerable expertise in clinical ASC research; the
PCC—extraordinarily—is bringing one million dollars and the “reach” of
the Church’s influence. The New York Daily News reported on May 25 that
the money will come from two foundations, but the Vatican has not
revealed their names [1].
|
|
Read more...
|
|
07/14/2010
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
|
This question is very insightful and well formulated. Although I believe
that embryo adoption is in principle legitimate and even can be
praiseworthy, the problem of unintended harmful consequences is very
real.
|
|
Read more...
|
|
04/01/2010
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
|
This is the second part of a two-part series on the U.S. Bishops’ newdocument on reproductive technology, Life-Giving Love in an Age ofTechnology, issued on November 17(www.usccb.org/LifeGivingLove/lifegivinglovedocument.pdf ). In thefirst essay I discussed the document’s ethical framework for analyzingparticular forms of reproductive assistance. In this essay I reviewthe document’s ethical teaching on the following forms: using gametedonors, surrogate motherhood, homologous artificial insemination, invitro fertilization, and cloning. Each consideration is brief. Ifinterest is expressed, I’d be happy to develop one or another of thearguments in a future blast.
|
|
Read more...
|
|
12/21/2009
|
|
by William E. May, Ph.D., Senior Fellow
|
The term “bioethics” is of recent coinage. The first to use it was Van
Rensselaer of the University of Wisconsin in the late 1960’s, an
oncologist who used it in an evolutionary sense somewhat distant from
the sense it has acquired. Warren T. Reich, one of the original
professors at what was then called the “The Joseph and Rose Kennedy
Institute for the Study of Human Reproduction and Bioethics” at
Georgetown University and editor of the first edition of the 4 volume
Encyclopedia of Bioethics, credits André Hellegers, the Dutch
obstetrician/fetal physiologist/demographer who founded the Kennedy
Institute at Georgetown University as the one “who used the term to
apply to the ethics of medicine and the biological sciences in such a
way that the name caught on in academic circles and in the mind of the
public. He did this initially by seeing to it that the word bioethics
appeared in the original name of the Kennedy Institute at its founding
in 1971: The Joseph and Rose Kennedy Institute for the Study of Human
Reproduction and Bioethics” (see Reich’s essay, “How Bioethics Got Its
Name” in The Hastings Center Report, Vol. 23, 1993).
|
|
Read more...
|
|
06/16/2009
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
Earlier this year, seven directors of bioethics programs at Jesuit
universities, calling themselves the Consortium of Jesuit Bioethics
Programs, published in Commonweal a critique of papal teaching on the
moral requirement to provide food and water to patients in the
so-called persistent vegetative state (PVS). [1] Their aim is to
influence the American bishops against amending the Ethical and
Religious Directives for Catholic Health Care Services (ERDs) to bring
the directives in line with the March 2004 teach¬ing of Pope John Paul
II on PVS. [2] The amendment will be considered at the bishops’ June
2009 meeting.
|
|
Read more...
|
|
06/11/2009
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
Even those minimally familiar with the stem cell debate are aware of
the vast disparity that presently exists between the clinical
usefulness of human adult stem cells (hASCs) and embryonic stem cells
(hESCs). Not only have hESCs, despite billions of dollars spent, not
given rise to a single clinical success (none, zero); but until
recently, there had not even been a single clinical trial using hESCs
accepted by the Food and Drug Administration (FDA). This illustrates
the concern of that regulatory body and the wider field for the serious
problems associated with hESC therapies, the most serious of which is
tumor formation.
|
|
Read more...
|
|
05/26/2009
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
Cypriot born reproductive scientist Panos Zavos is up to his old
mischief, claiming this time to have cloned 14 human embryos and to
have transferred 11 of them into the wombs of four women happy to give
birth to cloned babies. This is his third public announcement in six
years claiming to have succeeded at the controversial procedure [1].
Zavos, a naturalized American citizen, has fertility clinics in
Kentucky and in Cyprus. The British Independent reports that his
present work took place at a secret laboratory in a country where
cloning is legal (it speculates somewhere in the Middle East) [2].
|
|
Read more...
|
|
05/07/2009
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
Because of heightened interest in my last piece, Stem Cells for
Dummies, I decided to pursue further questions pertaining to scientific
interest in embryonic stem cells (ESCs).
|
|
Read more...
|
|
04/09/2009
|
|
by E. Christian Brugger, Ph.D., Senior Fellow in Ethics
|
What is a Stem Cell?
A stem cell is an undifferentiated cell (i.e., a cell that has not
yet specialized into a particular cell type, e.g., liver cell,
pancreatic cell, or cardiac cell) with two unique capacities: the
first, for rapid and prolonged self-multiplication into daughter cells
identical with itself; and the second, for development and
differentiation into specific types of cells such as liver and cardiac
cells.
|
|
Read more...
|
|
03/19/2009
|
|
by William E. May, Ph.D., Senior Fellow
|
|
September 8, 2008 is the official date of a new doctrinal document prepared by the Congregation for the Doctrine of the Faith (CDF) and approved by Pope Benedict XVI on bioethical issues. It is a sequel to the CDF’s February 1987 doctrinal Instruction on Respect for Human Life in Its Origins and on the Dignity of Procreation (Latin title Donum vitae). Dignitas Personae (henceforth DP), formally released for publication on December 12, 2008, is of a doctrinal nature and falls within the category of documents that "participate in the ordinary Magisterium of the successor of Peter" (see Instruction Donum veritatis, no.18), and is to be received by Catholics "with the religious assent of their spirit" (DP, no. 37).
|
|
Read more...
|
|
01/15/2009
|
|
by E. Christian Brugger, P.h.D, Senior Fellow in Ethics
|
Imagine a day when patients suffering from tuberculosis could go down to a hospital and trade in their diseased windpipes for a brand-spanking-new model custom built from their own cells and live free of the disease. Or where parents of congenitally brain damaged children could purchase a blood transfusion cocktail that would unlock the world of mental normality for their beloved children. Or where heart-attack victims could receive cardiac injections of miracle cells that not only would heal their damaged heart muscle, but also stimulate new blood vessel growth in their hearts and reduce scar tissue from the injury? Say ‘good morning’ to the stem cell revolution because that day has begun. I should be more precise: the ADULT stem cell revolution HAS BEGUN. Remarkably, these are not the dreams of some distant future but the treatments and possibilities opening before us right now.
|
|
Read more...
|
|
12/11/2008
|
|
by Christian Brugger Ph.D
|
A few encouraging stem cell updates. First, last month the online journal Nature published the results of experiments in mice by a team at the Harvard Stem Cell Institute in which common cells in the pancreas were converted into more precious insulin producing cells, precisely the kind that diabetics need to survive. And the most extraordinary thing: the conversion took place inside the body of the living mice.
|
|
Read more...
|
|
10/02/2008
|
|
by William E. May, Ph.D
|
|
This helpful book could be called “Catholic Bioethics for Everyone.” Dividing their material into an introduction and seven chapters subdivided into 57 questions, Smith and Kaczor offer a broad view of major life issues in easy-to-understand language. One of their major goals is to help fellow Catholics and others to understand the reasons behind Church teaching on crucial issues concerning human life; they also hope that their presentation of fundamental principles will guide readers in making their own choices on disputed questions on which the Church has not taken a firm stance (pp. xiii-xix).
|
|
Read more...
|
|
09/22/2008
|
|
by Christian Brugger, Ph.D.
|
|
Fellow in Ethics Christian Brugger clarifies, in layman terms, what it is to be: To be who we are when we were an embryo.
|
|
Read more...
|
|
03/20/2008
|
|
by Christian Brugger, Ph.D
|
Culture of Life Fellow in Ethics, Dr. Christian Brugger, explains the development, process, ethics and scientific contributions of Induced Pluripotent State Stem Cells.
|
|
Read more...
|
|
03/07/2008
|
|
by Jennifer Kimball, B.E.L.
|
A collage of headlines covering Monday’s breakthrough in stem cell research, published in the scientific journals, Science and Cell, attempt to state what, to many, is not so obvious. What we have found are pluripotent stem cells, equal to, but not to be confused with pluripotent embryonic stem cells.
|
|
Read more...
|
|
11/21/2007
|
|
by Mark Adams
|
|
Scientists from Harvard and California announced at a recent conference their intent to clone human embryos and destroy them for their stem cells and are hoping to succeed where disgraced South Korean scientist Woo-Suk Hwang dramatically failed. Hwang, who claimed to be the first in the world to successfully clone humans, was discredited in January after it was revealed he had fabricated almost all of his data.
|
|
Read more...
|
|
04/19/2006
|
|
by Mark Adams
|
|
Scientists in Germany have discovered another possible source for embryonic-like stem cells that can be obtained without destroying a human embryonic life. Researchers found that stem cells taken from the testes of mice have many of the characteristics of embryonic stem cells. The scientists were able to take those stem cells and turn them into heart, brain and skin cells and successfully inject them back into mice.
|
|
Read more...
|
|
03/29/2006
|
|
by Wendy Wright
|
|
The FDA broke its own rules in the fast-track approval of the “abortion pill.” Sadly, women are paying with their lives. Most people assume that advances made in medicine and science are helpful—and save lives. Regrettably, that is not always true. In the case of the abortion pill, RU-486, women are not helped—and lives are certainly not saved. Yet in September of 2000, the Food and Drug Administration (FDA) approved RU-486, or Mifeprex, for sale in the United States—a drug whose only purpose is to kill human beings.
|
|
Read more...
|
|
01/31/2006
|
|
by Culture of Life
|
|
Revelations that South Korean doctor Woo Suk Hwang, once thought to be the groundbreaking creator of the world's first cloned human embryos, fabricated all of his research has forced many mainstream media outlets to concede that human cloning and embryo destructive research were dealt a serious blow by the scandal. Despite efforts by some proponents of cloning to spin the story into a case for federally-funded research, Hwang has been largely portrayed as a disgraced scientist who has thrown the future of human cloning into jeopardy.
|
|
Read more...
|
|
01/04/2006
|
|
|
|
|
|
| |
|
Visit our Bioethics
and
Receive Culture of Life Briefs
bi-weekly in your e-mail!
|
|
|
|
|
|